Hypericum perforatum methanolic extract inhibits growth of human prostatic carcinoma cell line orthotopically implanted in nude mice
Authors:
- 16 March 2004
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 210 (1) , 27-33
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Hypericum perforatum versus fluoxetine in the treatment of mild to moderate depressionAdvances in Therapy, 2002
- Clinical trials with Hypericum extracts in patients with depression – Results, comparisons, conclusions for therapy with antidepressant drugsPhytomedicine, 2002
- Equivalence of St Johnʼs wort extract (Ze 117) and fluoxetine: a randomized, controlled study in mildmoderate depressionInternational Clinical Psychopharmacology, 2000
- Neuroendocrine cells in tumour growth of the prostate.Endocrine-Related Cancer, 1999
- Cancer statistics, 1999CA: A Cancer Journal for Clinicians, 1999
- Hypericum LI 160 inhibits uptake of serotonin and norepinephrine in astrocytesBrain Research, 1999
- Effects of Hypericum Extract (LI 160) in Biochemical Models of Antidepressant ActivityPharmacopsychiatry, 1997
- Growth-Inhibitory Effects of Serotonin Uptake Inhibitors on Human Prostate Carcinoma Cell LinesJournal of Urology, 1995
- Active cell death in hormone-dependent tissuesCancer and Metastasis Reviews, 1992
- Neuroendocrine differentiation in carcinoma of the prostate. Diagnostic, prognostic, and therapeutic implicationsCancer, 1992